• Watch Frank’s Daily Updates
  • How you could've bought KODK before it surged 1,500%
  • Forget tech: this sector has much more potential!

How to Turn $10,000 into $260,000!

05-02-dividendsWelcome to another episode of Wall Street Unplugged!

My guest this week is longtime friend, Marc Lichtenfeld, Chief Income Strategist at the Oxford Club.

Marc joins me in talks about perpetual dividend raisers and the absolute fortune investors can make by compounding dividends over long periods. He also shares one of his secrets to buying some of the best high-yielding companies at dirt cheap prices.

[app_audio src=”http://traffic.libsyn.com/sainvestorradio/WSU20EP20444.mp3″]

Marc then breaks down the biotech sector, an industry he’s covered for years. He talks about one specific area that holds huge promise to discovering cures for cancer, Alzheimer’s and Parkinson’s disease.

Also, he shares with us his favorite small-cap biotech name to buy right now.

Don’t miss out on this week’s educational segment covering some unique technologies investors need to be aware of. Discussed is a sector already having a tremendous affect on patients, significantly extending the lives of the unfortunate and elderly.

As always, thank you for tuning in and good investing!

Links & Resources

  • Stay updated with Marc Lichtenfeld here on his site OxfordClubRadio.com
  • Discover some of Marc’s most recent podcasts on Itunes here
  • Mentioned interview with former DEA agent Robert Mazur
  • Mentioned interview with Frank Abagnale Jr.
  • Marc’s book, Get Rich with Dividends

Stocks Mentioned

  • Chipotle (CMG)
  • 3M (MMM)
  • Hewlett Packard (HPQ)
  • International Business Machines (IBM)
  • Gap (GPS)
  • Darden Restaurants (DRI)
  • Biogen Inc. (BIIB)
  • Amgen Inc. (AMGN)
  • Intel Corporation (INTC)
  • Bio-tech ETF (IBB)
  • GW Pharmaceuticals (GWPH)
  • Foundation Medicine (FMI)
  • Illumina Inc. (ILMN)
  • Pfizer (PFE)
  • Bristol-Myers Squibb (BMY)
  • Prana Biotechnology (PRAN)
  • Corbus Pharmaceuticals (CRBP)
  • Pluristem Therapeutics (PSTI)
  • Brainstorm Cell Therapeutics (BCLI)
  • BioTime (BTX)


Chris MacIntosh

Prepare for a short-term pullback

Chris MacIntosh, founder and editor of Capitalist Exploits and founder/managing partner of the Asymmetric Opportunities Fund, explains why unprecedented government action could act as a tailwind for both gold and cryptocurrencies. Plus, why you should expect a short-term pullback in the markets...
Listen Now
Keith Neumeyer

Get ready for $100 silver prices

Keith Neumeyer, president and CEO of First Majestic Silver Corp., breaks down the current bull market in precious metals... why it could send silver over $100 per ounce... and some names he likes in the space. Plus: What you need to know about the race to find a COVID-19 vaccine.
Listen Now
Roller coaster markets got you confused?

New briefing tells you what you need to know... and what you need to do.